Chaine G, Haouat M, Menard-Molcard C, Favard C, Vignal-Clermont C, Campinchi-Tardy F, Massin P, Gaudric A, Badelon I, Nicolon L, Sabatier P, Guillevin L
Service d'Ophtalmologie, Hôpital Avicenne, 125, route de Stalingrad, 93009 Bobigny Cedex - France.
J Fr Ophtalmol. 2001 Feb;24(2):139-46.
The manifestations of the ocular toxicity of systemic corticosteroids include posterior subcapsular cataracts and glaucoma. We describe 14 cases of serous detachment of the macula due to central serous chorioretinopathy in patients given long-term steroid therapy, which may be another potential ocular side effect of corticosteroid.
The 14 (9 men and 5 women) patients were aged from 39 to 55 year old. Their systemic diseases were allergic thrombopenic purpura, optic neuritis, kidney or heart transplant, Churg and Strauss vasculitis, facial palsy, rheumatoid arthritis, systemic lupus and a kidney tumor. None of the patients had hypertension.
Serous detachment occurred between 6 days and 10 years after the start of steroid treatment. The higher the doses, the earlier the onset of ocular disease. All patients were symptomatic, with rapid onset of blurred vision. Serous detachment was bilateral in two cases. The fluorescein angiographic finding was in most cases a single small focal hyperfluorescent leak from the retinal pigment epithelium which appeared early in the angiogram and increased in size and intensity. No diffuse degradation of the retinal pigment epithelium was seen on the fluorescein angiogram. Five patients underwent laser photocoagulation of the leaking area followed by resorption of subretinal fluid. In other patients, the symptoms disappeared as the doses of steroid were reduced.
The pathogenesis of central serous chorioretinopathy remains unclear and is controversial. Corticosteroids are known to worsen the prognosis of idiopathic central serous chorioretinopathy, and serous detachment has been reported after renal transplantation. In most of these cases, chorioretinopathy was combined with diffuse leakage from the choriocapillaris. We discuss the relationship between steroid therapy and focal leakage as seen in idiopathic central serous chorioretinopathy. In conclusion, we describe 14 cases of central serous retinopathy whose clinical and fluorescein angiography were fairly typical, without obvious diffuse degradation of the retinal pigment epithelium. All these patients had been given long-term steroid therapy for various diseases.
全身用皮质类固醇激素的眼部毒性表现包括后囊下白内障和青光眼。我们描述了14例长期接受类固醇治疗的患者因中心性浆液性脉络膜视网膜病变导致的黄斑浆液性脱离,这可能是皮质类固醇激素的另一种潜在眼部副作用。
14例患者(9例男性,5例女性)年龄在39至55岁之间。他们的全身性疾病包括过敏性血小板减少性紫癜、视神经炎、肾或心脏移植、变应性肉芽肿性血管炎、面神经麻痹、类风湿关节炎、系统性红斑狼疮和肾肿瘤。所有患者均无高血压。
浆液性脱离发生在类固醇治疗开始后的6天至10年之间。剂量越高,眼病发作越早。所有患者均有症状,视力模糊起病迅速。2例患者为双侧浆液性脱离。荧光素血管造影检查结果在大多数情况下是视网膜色素上皮的单个小局灶性高荧光渗漏,在血管造影早期出现,大小和强度增加。荧光素血管造影未见视网膜色素上皮弥漫性退变。5例患者对渗漏区进行了激光光凝,随后视网膜下液吸收。在其他患者中,随着类固醇剂量的减少,症状消失。
中心性浆液性脉络膜视网膜病变的发病机制尚不清楚且存在争议。已知皮质类固醇激素会使特发性中心性浆液性脉络膜视网膜病变的预后恶化,肾移植后也有浆液性脱离的报道。在大多数这些病例中,脉络膜视网膜病变合并脉络膜毛细血管弥漫性渗漏。我们讨论了类固醇治疗与特发性中心性浆液性脉络膜视网膜病变中所见局灶性渗漏之间的关系。总之,我们描述了14例中心性浆液性视网膜病变,其临床和荧光素血管造影表现相当典型,无明显视网膜色素上皮弥漫性退变。所有这些患者均因各种疾病接受了长期类固醇治疗。